Updates, Opportunities & Community Highlights. Over the past few months, we’ve seen a wave of momentum, connection, and hope across the LMNA cardiac landscape.
LMNA Cardiac Newsletter
Updates, Opportunities & Community Highlights
Dear LMNA Cardiac,
Over the past few months, we’ve seen a wave of momentum, connection, and hope across the LMNA cardiac landscape. From groundbreaking regulatory news to international collaboration, hereβs whatβs new:
π’ Highlights from the 2025 Laminopathies Meeting
Our team recently returned from the 2025 Laminopathies Meeting in Paris, filled with gratitude and renewed energy. This gathering brought together global researchers, clinicians, and advocates to share updates and strengthen ties. Read our reflections and key takeaways.
β FDA Clears IND for Gene Therapy Targeting LMNA-Related DCM
In an exciting regulatory milestone, the FDA has cleared the Investigational New Drug (IND) application for NVC-001, a gene therapy candidate from NuevoCure, specifically targeting LMNA-related dilated cardiomyopathy.
𧬠Join Us Live: Understanding LMNA Cardiomyopathy β July 1st Event
Join LMNA experts from the Netherlands and the Heart Health India Foundation for a special Zoom session on LMNA-related cardiomyopathyβa rare genetic heart condition that can progress silently.
Tuesday, July 1, 2025 8β9 PM IST | 4:30β5:30 PM CEST Free registration
Learn about symptoms, diagnosis, treatment, and why early awareness matters.
πΉ Dr. Lisa Wilsbacher explains how LMNA gene variants are identified and interpreted in clinical settings, helping patients and families better understand their genetic reports.
π¬ Next Virtual Patient Chat β August 31, 2025
Join us for our next LMNA community video group chat β a welcoming space to connect, ask questions, and support one another. ποΈ Sunday, August 31, 12β1:30pm EST / 6β7:30pm CEST
Weβre excited to share that the LMNA Priority initiative now has its own website! Learn about our collaborative international effort to drive forward research and awareness.
𧬠Free Genetic Testing Now Available for Eligible Families
If you or a family member has been diagnosed with cardiomyopathy, you may qualify for no-cost genetic testing and counseling through the Genetic Cardiomyopathy Awareness Consortium. Early genetic insights can empower families to make informed health decisions and contribute to research.
Thank you for being part of this community. Whether you’re a patient, caregiver, clinician, or researcher, your involvement is helping push the field forward β and weβre so grateful to be on this journey with you.β€οΈ
Every contribution, regardless of its amount, fuels crucial efforts in research, medical education, patient advocacy, and raising awareness about LMNA cardiac diseases.
You can make a difference in various ways: by committing as a regular monthly donor, offering a single donation, organizing fundraising events both online and in person, contributing to our special tribute funds, or through your unique fundraising initiatives!